Bioxytran, Inc (BIXT) stock
BIXTOTCPharmaceutical PreparationsFiscal year ends December 31
$0.02−0.00 (-3.95%)
Close on Oct 19, 2026Market cap $2.56MP/E –Yield –
Bioxytran total assets
Total assets on the balance sheet at the end of each period.
Bioxytran's total assets was $333.39K at Jun 30, 2026. For fiscal 2025 it was $658.55K, up 374.8% from the year before. Over ten years it grew 28.0% a year on average. The highest annual figure on record is $658.55K in fiscal 2025.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $658.55K | +374.8% |
| FY2024 | Dec 31, 2024 | $138.69K | -0.5% |
| FY2023 | Dec 31, 2023 | $139.38K | -62.4% |
| FY2022 | Dec 31, 2022 | $370.94K | +211.0% |
| FY2021 | Dec 31, 2021 | $119.29K | -63.5% |
| FY2020 | Dec 31, 2020 | $326.40K | +48.6% |
| FY2019 | Dec 31, 2019 | $219.63K | +503.2% |
| FY2018 | Dec 31, 2018 | $36.41K | +33000.9% |
| FY2017 | Dec 31, 2017 | $110 | -99.8% |
| FY2016 | Dec 31, 2016 | $51.67K | -7.4% |
| FY2015 | Dec 31, 2015 | $55.82K | -50.7% |
| FY2014 | Dec 31, 2014 | $113.28K | -56.2% |
| FY2013 | Dec 31, 2013 | $258.44K | -39.7% |
| FY2012 | Dec 31, 2012 | $428.44K | +98.3% |
| FY2011 | Dec 31, 2011 | $216.09K | +167.7% |
| FY2010 | Dec 31, 2010 | $80.73K | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $333.39K | +126.0% |
| Q1 FY2026 | Mar 31, 2026 | $615.25K | +352.2% |
| Q4 FY2025 | Dec 31, 2025 | $658.55K | +374.8% |
| Q3 FY2025 | Sep 30, 2025 | $156.29K | -1.7% |
| Q2 FY2025 | Jun 30, 2025 | $147.50K | +14.7% |
| Q1 FY2025 | Mar 31, 2025 | $136.05K | +8.4% |
| Q4 FY2024 | Dec 31, 2024 | $138.69K | -0.5% |
| Q3 FY2024 | Sep 30, 2024 | $159.01K | -15.9% |
| Q2 FY2024 | Jun 30, 2024 | $128.55K | -10.1% |
| Q1 FY2024 | Mar 31, 2024 | $125.54K | -46.2% |
| Q4 FY2023 | Dec 31, 2023 | $139.38K | -62.4% |
| Q3 FY2023 | Sep 30, 2023 | $189.04K | -57.9% |
| Q2 FY2023 | Jun 30, 2023 | $143.06K | -74.8% |
| Q1 FY2023 | Mar 31, 2023 | $233.53K | -71.1% |
| Q4 FY2022 | Dec 31, 2022 | $370.94K | +211.0% |
| Q3 FY2022 | Sep 30, 2022 | $448.54K | -41.2% |
| Q2 FY2022 | Jun 30, 2022 | $568.23K | -37.3% |
| Q1 FY2022 | Mar 31, 2022 | $807.93K | +109.7% |
| Q4 FY2021 | Dec 31, 2021 | $119.29K | -63.5% |
| Q3 FY2021 | Sep 30, 2021 | $762.25K | +120318.3% |
| Q2 FY2021 | Jun 30, 2021 | $906.30K | +21244.7% |
| Q1 FY2021 | Mar 31, 2021 | $385.30K | +777.9% |
| Q4 FY2020 | Dec 31, 2020 | $326.40K | +48.6% |
| Q3 FY2020 | Sep 30, 2020 | $633 | -98.1% |
| Q2 FY2020 | Jun 30, 2020 | $4.25K | -90.6% |
| Q1 FY2020 | Mar 31, 2020 | $43.89K | -63.1% |
| Q4 FY2019 | Dec 31, 2019 | $219.63K | +503.2% |
| Q3 FY2019 | Sep 30, 2019 | $33.23K | +1073.6% |
| Q2 FY2019 | Jun 30, 2019 | $45.28K | -93.4% |
| Q1 FY2019 | Mar 31, 2019 | $118.93K | -82.8% |
| Q4 FY2018 | Dec 31, 2018 | $36.41K | +33000.9% |
| Q3 FY2018 | Sep 30, 2018 | $2.83K | -96.3% |
| Q2 FY2018 | Jun 30, 2018 | $686.21K | +3082.0% |
| Q1 FY2018 | Mar 31, 2018 | $691.70K | +2266.7% |
| Q4 FY2017 | Dec 31, 2017 | $110 | -99.8% |
| Q3 FY2017 | Sep 30, 2017 | $76.76K | -6.2% |
| Q2 FY2017 | Jun 30, 2017 | $21.57K | – |
| Q1 FY2017 | Mar 31, 2017 | $29.23K | – |
| Q4 FY2016 | Dec 31, 2016 | $51.67K | – |
| Q3 FY2016 | Sep 30, 2016 | $81.83K | – |
See a number that looks wrong?